Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92,448,158
-
Total 13F shares
-
8,239,628
-
Share change
-
-75,045
-
Total reported value
-
$133,896,000
-
Price per share
-
$16.25
-
Number of holders
-
45
-
Value change
-
-$2,329,398
-
Number of buys
-
33
-
Number of sells
-
14
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q3 2018
As of 30 Sep 2018 Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) had 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,239,628 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, Fosun International Ltd, FMR LLC, Vanguard Group Inc, BlackRock Inc., KORNITZER CAPITAL MANAGEMENT INC /KS, FIL Ltd, GILDER GAGNON HOWE & CO LLC, and CONNING INC..
This table shows 45 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.